Time-Resolved Fluorescence Imaging and Correlative Cryo-Electron Tomography to Study Structural Changes of the HIV-1 Capsid

  • ACS Nano. 2025 Sep 2;19(34):30902-30918. doi: 10.1021/acsnano.5c06724.
Zaida K Rodriguez  1  2 Jonathan R Andino-Moncada  3 Sergey A Buth  4 Atousa Mehrani  1 Ahinsa Ranaweera  3 Jincheng Shi  3 Leonardo R Andrade  1 Satya Prakash Singh  3 Timothy S Strutzenberg  1 Mariana Marin  4 Ricardo Guerrero-Ferreira  5 Hamid Rahmani  6 Danielle A Grotjahn  6 Scott Stagg  3 Gregory B Melikyan  4 Dmitry Lyumkis  1  2  6 Ashwanth C Francis  3
Affiliations
  • 1. The Salk Institute for Biological Sciences, La Jolla, San Diego, California 92037, United States.
  • 2. Department of Molecular Biology, School of Biological Sciences, University of California, La Jolla, San Diego, California 92037, United States.
  • 3. Institute of Molecular Biophysics and Department of Biological Sciences, Florida State University, Tallahassee, Florida 32306, United States.
  • 4. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
  • 5. Robert P. Apkarian Integrated Electron Microscopy Core, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
  • 6. Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, California 92037, United States.
Abstract

The conical HIV-1 capsid protects the internal viral genome and facilitates the Infection of target cells. Highly potent antivirals, such as the clinically approved drug Lenacapavir (LEN), block HIV-1 replication by changing the capsid structure and modulating its function. However, structural studies of the HIV-1 capsid, its disassembly, or stabilization by antivirals have been challenging. Here, we developed a correlative light and cryo-electron microscopy (CLEM) workflow to characterize HIV-1 capsid morphology, starting from a small volume of viral particles harvested from cellular supernatants. We report two critical improvements in sample preparation, namely, (1) affinity capture and retention of fluorescent HIV-1 particles on cryo-EM grids to enable mapping virus/capsid location prior to sample vitrification and (2) streamlined alignment protocols to subsequently identify and correlate regions of interest in fluorescence and cryo-EM images. These improvements enable a reproducible CLEM workflow to accurately locate capsids for cryo-electron tomography (cryo-ET) studies. Using this approach, we resolved ultrastructures of HIV-1 capsids treated with LEN and the cellular metabolite inositol hexaphosphate (IP6), revealing distinct modes of capsid lattice stabilization. Finally, using our CLEM workflow, we demonstrate the feasibility of correlating time-resolved fluorescence imaging of capsid disassembly to end point cryo-ET structures. These advances will facilitate in vitro structural studies to define the mechanisms of HIV-1 capsid stabilization and disassembly. The CLEM workflow developed here can also be extended to studying structural changes in Other viruses in response to diverse stimuli.

Keywords
CLEM; HIV-1 capsid uncoating; IP6; cryo-ET; lenacapavir.
Products